What is the address of Smets Leonie, Klinisch Bioloog?

The registered office of Smets Leonie, Klinisch Bioloog is located at Alex Vermaelenstraat 10, 3052 Oud-Heverlee.

Is Smets Leonie, Klinisch Bioloog still active?

Yes. According to the CBE (30 September 2026) Smets Leonie, Klinisch Bioloog is active, legal situation “Normale toestand”, started on 24 August 2021.

Is Smets Leonie, Klinisch Bioloog registered on Peppol?

Yes, Smets Leonie, Klinisch Bioloog is registered on the Peppol network with ID 0208:0772813549.

What is the enterprise number of Smets Leonie, Klinisch Bioloog?

The enterprise number of Smets Leonie, Klinisch Bioloog is BE0772813549.

When was Smets Leonie, Klinisch Bioloog founded?

Smets Leonie, Klinisch Bioloog was founded on 24 August 2021.

Who are the directors of Smets Leonie, Klinisch Bioloog?

According to the 2025 annual accounts, the directors of Smets Leonie, Klinisch Bioloog are: Leonie Smets.

Is Smets Leonie, Klinisch Bioloog a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 August 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Smets Leonie, Klinisch Bioloog make in 2025?

Smets Leonie, Klinisch Bioloog posted a profit after taxes of € 150,381 in financial year 2025.

What is the revenue of Smets Leonie, Klinisch Bioloog?

As a small company, Smets Leonie, Klinisch Bioloog is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 203,886.

Smets Leonie, Klinisch Bioloog (Private Limited)

Dossier Smets Leonie, Klinisch Bioloog, printed on 30 September 2026 from databakkes.be/en/0772813549/smets-leonie-klinisch-bioloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Smets Leonie, Klinisch Bioloog from Oud-Heverlee, company number BE0772813549, closed financial year 2025 with a result of € 150,381 after tax. For that financial year Smets Leonie, Klinisch Bioloog recorded a gross margin of € 203,886 and equity of € 156,450. Compared with financial year 2024, the result moved from € 50,308 to € 150,381. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 19, 2026.

What it is worth Growing

€ 156,450

▲ 86% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 150,381

▲ 199% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 141,975

▲ 183% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 78,000 paid out

52 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 23,626

▲ 10% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 977

▼ 51% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,753

▲ € 3,734 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 82,819 Gross margin 2022: € 82,819 First fiscal year in the series	€ 94,575 Gross margin 2023: € 94,575 ▲ 14% vs 2022 (€ 82,819) Favourable step	€ 76,454 Gross margin 2024: € 76,454 ▼ 19% vs 2023 (€ 94,575) Unfavourable step	€ 203,886 Gross margin 2025: € 203,886 ▲ 167% vs 2024 (€ 76,454) Favourable step	▲ 167%
Profit after taxes	€ 65,500 Profit after taxes 2022: € 65,500 First fiscal year in the series	€ 71,847 Profit after taxes 2023: € 71,847 ▲ 10% vs 2022 (€ 65,500) Favourable step	€ 50,308 Profit after taxes 2024: € 50,308 ▼ 30% vs 2023 (€ 71,847) Unfavourable step	€ 150,381 Profit after taxes 2025: € 150,381 ▲ 199% vs 2024 (€ 50,308) Favourable step	▲ 199%
Equity	€ 81,914 Equity 2022: € 81,914 First fiscal year in the series	€ 153,761 Equity 2023: € 153,761 ▲ 88% vs 2022 (€ 81,914) Favourable step	€ 84,069 Equity 2024: € 84,069 ▼ 45% vs 2023 (€ 153,761) Unfavourable step	€ 156,450 Equity 2025: € 156,450 ▲ 86% vs 2024 (€ 84,069) Favourable step	▲ 86%
Total debts	€ 13,030 Total debts 2022: € 13,030 First fiscal year in the series	€ 7,872 Total debts 2023: € 7,872 ▼ 40% vs 2022 (€ 13,030) Favourable step	€ 7,641 Total debts 2024: € 7,641 ▼ 3% vs 2023 (€ 7,872) Favourable step	€ 10,367 Total debts 2025: € 10,367 ▲ 36% vs 2024 (€ 7,641) Unfavourable step	▲ 36%
Cash	€ 82,238 Cash 2022: € 82,238 First fiscal year in the series	€ 121,175 Cash 2023: € 121,175 ▲ 47% vs 2022 (€ 82,238) Favourable step	€ 50,140 Cash 2024: € 50,140 ▼ 59% vs 2023 (€ 121,175) Unfavourable step	€ 141,975 Cash 2025: € 141,975 ▲ 183% vs 2024 (€ 50,140) Favourable step	▲ 183%
Retained profit	€ 75,914 Retained profit 2022: € 75,914 First fiscal year in the series	€ 147,761 Retained profit 2023: € 147,761 ▲ 95% vs 2022 (€ 75,914) Favourable step	€ 78,069 Retained profit 2024: € 78,069 ▼ 47% vs 2023 (€ 147,761) Unfavourable step	€ 150,450 Retained profit 2025: € 150,450 ▲ 93% vs 2024 (€ 78,069) Favourable step	▲ 93%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 120,000 Dividend 2024: € 120,000 Unchanged (€ 0) Unchanged	€ 78,000 Dividend 2025: € 78,000 ▼ 35% vs 2024 (€ 120,000) Unchanged	▼ 35%
Balance sheet total	€ 94,944 Balance sheet total 2022: € 94,944 First fiscal year in the series	€ 161,632 Balance sheet total 2023: € 161,632 ▲ 70% vs 2022 (€ 94,944) Unchanged	€ 91,709 Balance sheet total 2024: € 91,709 ▼ 43% vs 2023 (€ 161,632) Unchanged	€ 166,817 Balance sheet total 2025: € 166,817 ▲ 82% vs 2024 (€ 91,709) Unchanged	▲ 82%

Key figures of Smets Leonie, Klinisch Bioloog, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Smets Leonie, Klinisch Bioloog?

What happened at Smets Leonie, Klinisch Bioloog in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 19, 2026 New annual accounts for financial year 2025: profit of € 150,381 (▲ 199% vs 2024). Source: NBB ↗
Aug 24, 2021 New establishment in Oud-Heverlee. KBO
2021 Leonie Smets became a director. NBB
Aug 24, 2021 Start of the company according to the CBE. KBO

In short

From € 65,500 profit in 2022 to € 150,381 profit in 2025.

Paid € 98,404 in corporate taxes since 2022.

Best year ever: 2025, with € 150,381 profit.

Paid out € 198,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Smets Leonie, Klinisch Bioloog? We notify you, reason included.

Follow Smets Leonie, Klinisch Bioloog

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Leonie Smets

Smets Leonie, Klinisch Bioloog

Behind Smets Leonie, Klinisch Bioloog is Leonie Smets.

See the full network in the app

Directors

According to the 2025 annual accounts

Leonie Smets

Andere functie

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Alex Vermaelenstraat 10

3052 Oud-Heverlee

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0772.813.549
VAT number: BE 0772.813.549
Registered office: Alex Vermaelenstraat 10, 3052 Oud-Heverlee
Names & denominations: Smets Leonie, Klinisch Bioloog
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 August 2021
Peppol: Active · Active since 28 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗